Switzerland· 55742002
Tractocile 37.5 mg / 5 ml, Konzentrat zur Herstellung einer Infusionslösung
A atosiban product, registered in Switzerland by Ferring AG and dispensed under Swissmedic category B. The same ATC class is registered in 14 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Atosiban is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX01 (atosiban), each read from that country’s own register.
- This record: Switzerland
- 8 of them publish a price we can compare per daily dose
Atosiban · ATC G02CX01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
- Manufacturer
- Ferring AG
- Country
- Switzerland (CH)
- ATC code
- G02CX01
- ATC class
- Atosiban
- Defined daily dose
- 165 mg, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G02CX01
Atosiban, as other registers publish it.
- DenmarkAtosiban "EVER Pharma"EVER Valinject GmbH
- DenmarkAtosiban "EVER Pharma"EVER Valinject GmbH
- DenmarkAtosiban "EVER Pharma"EVER Valinject GmbH
- DenmarkAtosiban "SUN"SUN Pharmaceutical Industries Europe BV
- DenmarkAtosiban "SUN"SUN Pharmaceutical Industries Europe BV
- United KingdomAtosiban 37.5mg/5ml concentrate for solution for infusion vialsAccord-UK Ltd
- United KingdomAtosiban 37.5mg/5ml concentrate for solution for infusion vialsBowmed Ibisqus Ltd
- United KingdomAtosiban 37.5mg/5ml concentrate for solution for infusion vialsSun Pharma UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df53bc58-ea81-4abe-b83f-852ba5b77d50 GET /v1/drugs/df53bc58-ea81-4abe-b83f-852ba5b77d50?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about atosiban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.